Koto, Yuta http://orcid.org/0000-0003-4314-4955
Yamashita, Wakana
Lee, Yoko
Hadano, Nozomi
Kokubu, Chikara
Sakai, Norio
Article History
Received: 13 June 2022
Accepted: 1 November 2022
First Online: 17 November 2022
Declarations
:
: This research was approved by the Osaka University Clinical Research Review Committee (No. 19077). Informed consent was obtained from all the participants included in the study.
: Participants were informed in writing that the data would be processed in such a way that individual information could not be identified, and the data would be published in an article or conference presentation. Their consent was obtained in writing.
: YK received research funding from Takeda Pharmaceutical Company Limited and has served as a consultant and appeared on speakers’ bureaus for Takeda. WY, YL, NH, CK, and NS declare that they have no conflicts of interest in association with this study.